# SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study

Study · id `cardio:ct-nct02959606` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02959606](<https://clinicaltrials.gov/study/NCT02959606>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02959606

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 272 participants.

## Technical summary

Registry record NCT02959606. Randomized; no masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2019-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 272 participants (planned count; ClinicalTrials.gov record NCT02959606, source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)
- Start date: 2016-12 (registry gives no type) (ClinicalTrials.gov record NCT02959606, source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)
- Primary completion: 2019-01 (anticipated) (ClinicalTrials.gov record NCT02959606, source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)
- Completion: 2019-01 (anticipated) (ClinicalTrials.gov record NCT02959606, source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02959606, source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02959606-2017-07-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study
- Condition: Peripheral Arterial Disease
- Intervention (Drug): Sarpogrelate SR 300mg
- Intervention (Drug): Clopidogrel
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention (`cardio:pubmed-36781928`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7c0ed9d31545ecf7ca25e2675458dc240e1703242b999cdf187cd54952c396dc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
